This article is more than 5 years old. Information may no longer be current.

AMO wins patent infringement suit against Alcon

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SANTA ANA, Calif. — Advanced Medical Optics has won a lawsuit suit against Alcon for patent infringement of two patents for phacoemulsification equipment used during cataract surgery, according to a press release from AMO.

AMO was awarded $94.8 million in damages, and the company will seek a permanent injunction prohibiting Alcon from selling equipment with features that infringe the disputed patents, according to the AMO press release.

The two patents relate to occlusion mode and to a fluidics management system, the press release stated. AMO alleged that Alcon’s Infiniti infringed the fluidics patent and its Series 20000 AdvanTec and Everest Legacy machines infringed the occlusion patent.

In a separate press release, Alcon indicated that it believes “the jury verdict of infringement is not supported by the evidence and is incorrect as a matter of law.” The Alcon release said the company would ask the court to set aside the verdict and would appeal if necessary.

Alcon said in its release that the company expects the verdict to be set aside but has decided to make the software changes necessary to remove its Occlusion Power Management feature — the feature in contention — because “few, if any” of its customers used the option.